NL-OMON49657招募中不适用
Evaluation of Prostate-Specific Antigen Glycomics Assay for the Early Detection of Prostate Cancer - PSA Glyomics Assay (PGA)
Amsterdam UMC0 个研究点目标入组 225 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 225
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 64（—）
入选标准
- •Patients with a PSA concentration >3 ng/mL that visit the urologist for further
- •examination.
排除标准
- •Patients with a PSA concentration <3 ng/mL, patients that have a cystitis
- •(bladder infection), are in the process of undergoing chemo therapy or using
- •5-alpha reductase inhibitors will be excluded from the study. Patients with a
- •history or presence of cancers, or non-prostate urological disorders.
研究者
相似试验
招募中
不适用
PSA Glycomics Assay for Early Detection of Prostate CancerPSAProstate CancerNCT04393376Prof.dr. H.P. Beerlage150
招募中
2 期
Prostate-Specific Membrane Antigen (PSMA) Intensity Can be Altered by Androgen and phospho-SrC Obstructiometastatic castration-resistant prostate cancerCancer - ProstateACTRN12621000611820St Vincent's Hospital, Sydney22
尚未招募
不适用
Prostate-specific Membrane Antigen (PSMA) expression in cervical carcinomaC53.9Cervix uteri, unspecifiedDRKS00023289niversitätsklinikum FreiburgKlinik für Frauenheilkunde100
已完成
不适用
Prostate-specific Membrane Antigen (PSMA) expression in endometrial cancerC54Malignant neoplasm of corpus uteriDRKS00025005niversitätsklinikum Freiburg Klinik für Frauenheilkunde61
尚未招募
不适用
Prostate-specific membrane antigen (PSMA) expression in ovarian carcinomaC56Malignant neoplasm of ovaryDRKS00023240niversitätsklinikum Freiburg Klinik für Frauenheilkunde100